What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
James A. Fagin mostly deals with Thyroid cancer, Cancer research, Thyroid, Internal medicine and Thyroid carcinoma.
His Thyroid cancer study improves the overall literature in Cancer.
His Cancer research research is multidisciplinary, incorporating perspectives in Mutation, Point mutation, Carcinogenesis, Carcinoma and MAPK/ERK pathway.
His study explores the link between Thyroid and topics such as Pathology that cross with problems in PAX8, Lumen and Extracellular matrix.
His Internal medicine research includes themes of Endocrinology, Melanoma and Oncology.
His research in the fields of RET/PTC Rearrangement and Poorly Differentiated Thyroid Carcinoma overlaps with other disciplines such as EIF1AX.
His most cited work include:
- Integrated Genomic Characterization of Papillary Thyroid Carcinoma (1325 citations)
- High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. (1252 citations)
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial (898 citations)
What are the main themes of his work throughout his whole career to date?
James A. Fagin focuses on Internal medicine, Cancer research, Thyroid cancer, Endocrinology and Thyroid.
His Internal medicine research integrates issues from Cell culture, Messenger RNA, Oncology and Cell growth.
James A. Fagin focuses mostly in the field of Cancer research, narrowing it down to matters related to Carcinogenesis and, in some cases, Molecular biology.
His Thyroid cancer research is multidisciplinary, relying on both Survival rate and Disease.
His Endocrinology study integrates concerns from other disciplines, such as Receptor, Growth factor, Insulin-like growth factor and Gene expression.
He works mostly in the field of Thyroid, limiting it down to concerns involving Pathology and, occasionally, Adenocarcinoma.
He most often published in these fields:
- Internal medicine (48.00%)
- Cancer research (38.91%)
- Thyroid cancer (38.55%)
What were the highlights of his more recent work (between 2016-2021)?
- Thyroid cancer (38.55%)
- Cancer research (38.91%)
- Thyroid (32.73%)
In recent papers he was focusing on the following fields of study:
His main research concerns Thyroid cancer, Cancer research, Thyroid, Internal medicine and Mutation.
His study in Thyroid cancer is interdisciplinary in nature, drawing from both Radiology, PTEN, Thyroid carcinoma and Disease.
James A. Fagin has researched Cancer research in several fields, including Cancer, Tipifarnib, MEK inhibitor, Gene and HRAS.
His work in Thyroid addresses issues such as MAPK/ERK pathway, which are connected to fields such as Mutation, Germline mutation and Lysyl oxidase.
His Internal medicine research incorporates elements of Endocrinology and Oncology.
His Mutation research incorporates themes from Carcinogenesis, Melanoma, Chromatin remodeling, Kinase and In vivo.
Between 2016 and 2021, his most popular works were:
- Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance (142 citations)
- Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes. (70 citations)
- Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence. (50 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Thyroid cancer, Internal medicine, Thyroid, Oncology and Cancer research are his primary areas of study.
The concepts of his Thyroid cancer study are interwoven with issues in Pathology Report, Surgery, General surgery and Endocrine system.
James A. Fagin is studying Thyroid carcinoma, which is a component of Internal medicine.
His Thyroid study deals with the bigger picture of Endocrinology.
His research in Oncology intersects with topics in Survival rate and Cancer.
His Cancer research study incorporates themes from Mutation, Downregulation and upregulation, Gene and Tipifarnib.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
